Cargando…

Lipidomic Predictors of Coronary No-Reflow

The ‘no-reflow’ phenomenon (NRP) after primary percutaneous coronary intervention (PCI) is a serious complication among acute ST-segment elevation myocardial infarction (STEMI) patients. Herein, a comprehensive lipidomics approach was used to quantify over 300 distinct molecular species in circulati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Surendran, Arun, Ismail, Umar, Atefi, Negar, Bagchi, Ashim K., Singal, Pawan K., Shah, Ashish, Aliani, Michel, Ravandi, Amir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861202/ https://www.ncbi.nlm.nih.gov/pubmed/36677004 http://dx.doi.org/10.3390/metabo13010079

Ejemplares similares

Impact of myocardial reperfusion on human plasma lipidome
por: Surendran, Arun, et al.
Publicado: (2022)

Defining Acute Coronary Syndrome through Metabolomics
por: Surendran, Arun, et al.
Publicado: (2021)

IL-10 attenuates OxPCs-mediated lipid metabolic responses in ischemia reperfusion injury
por: Bagchi, Ashim K., et al.
Publicado: (2020)

Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention
por: Surendran, Arun, et al.
Publicado: (2019)

Lipidomics of Bioactive Lipids in Acute Coronary Syndromes
por: Solati, Zahra, et al.
Publicado: (2019)

Postpartum Endocarditis and Left Main Embolization
por: Atefi, Negar, et al.
Publicado: (2022)

Predictors of no-reflow in patients undergoing primary percutaneous coronary intervention. Thrombus aspiration was protective()
por: Hassan, Ayman K.M., et al.
Publicado: (2018)

Interleukin-10 Mitigates Doxorubicin-Induced Endoplasmic Reticulum Stress as Well as Cardiomyopathy
por: Malik, Akshi, et al.
Publicado: (2022)

When rotational atherectomy is not enough
por: Atefi, Negar, et al.
Publicado: (2021)

Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Shakiba, Maryam, et al.
Publicado: (2020)

Role of oxidative stress versus lipids in monocrotaline‐induced pulmonary hypertension and right heart failure
por: Farahmand, Firoozeh, et al.
Publicado: (2021)

Endoplasmic Reticulum Stress Promotes iNOS/NO and Influences Inflammation in the Development of Doxorubicin-Induced Cardiomyopathy
por: Bagchi, Ashim K., et al.
Publicado: (2021)

Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction
por: Mazhar, Jawad, et al.
Publicado: (2015)

Akt Regulates IL-10 Mediated Suppression of TNFα-Induced Cardiomyocyte Apoptosis by Upregulating Stat3 Phosphorylation
por: Dhingra, Sanjiv, et al.
Publicado: (2011)

Effects of streptokinase on reflow in rescue percutaneous coronary intervention
por: Sanatkar, Masoud, et al.
Publicado: (2013)

Capillary pericytes mediate coronary no-reflow after myocardial ischaemia
por: O'Farrell, Fergus M, et al.
Publicado: (2017)

Non-pharmaco, non-invasive management of coronary no-reflow phenomenon
por: Sinha, Santosh Kumar, et al.
Publicado: (2020)

CHA2DS2-VASc Score Predict No-Reflow Phenomenon in Primary Percutaneous Coronary Intervention in Primary Percutaneous Coronary Intervention
por: Mirbolouk, Fardin, et al.
Publicado: (2018)

Incidence, Predictors, and Prognosis of Coronary Slow-Flow and No-Reflow Phenomenon in Patients with Chronic Total Occlusion Who Underwent Percutaneous Coronary Intervention
por: Wang, Yong, et al.
Publicado: (2020)

Olive oil protects against progression of heart failure by inhibiting remodeling of heart subsequent to myocardial infarction in rats
por: Al‐Shudiefat, Abd Al‐Rahman, et al.
Publicado: (2022)

Overcoming the Bitter Taste of Oils Enriched in Fatty Acids to Obtain Their Effects on the Heart in Health and Disease
por: Stamenkovic, Aleksandra, et al.
Publicado: (2019)

The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis
por: Fajar, Jonny Karunia, et al.
Publicado: (2018)

Predictors of delayed and no-reflow as recognized with Thrombolysis in Myocardial Infarction [TIMI] flow grade following Primary Percutaneous Coronary Angioplasty
por: Bahrehmand, M, et al.
Publicado: (2015)

No-Reflow after PPCI—A Predictor of Short-Term Outcomes in STEMI Patients
por: Pantea-Roșan, Larisa Renata, et al.
Publicado: (2020)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome
por: Song, Nian-Peng, et al.
Publicado: (2020)

The SALINE Technique for the Treatment of the No-Reflow Phenomenon during Percutaneous Coronary Intervention in STEMI
por: Grancini, Luca, et al.
Publicado: (2023)

The role of insulin-like growth factor-1 in development of coronary no-reflow and severity of coronary artery disease in patients with acute myocardial infarction
por: Akturk, Ibrahim Faruk, et al.
Publicado: (2014)

Predilation Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization
por: Kumar, Rajesh, et al.
Publicado: (2023)

RDW as A Predictor for No-Reflow Phenomenon in DM Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Sun, Ying, et al.
Publicado: (2023)

Diagnostic Ultrasound and Microbubbles Treatment Improves Outcomes of Coronary No-Reflow in Canine Models by Sonothrombolysis
por: Li, Hairui, et al.
Publicado: (2018)

Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention
por: Alidoosti, Mohammad, et al.
Publicado: (2018)

Development of Multi-Vessel Coronary No-Reflow Following Elective Percutaneous Intervention in One Vessel
por: Hussain, Syed W, et al.
Publicado: (2023)

No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation
por: Maksimenko, Alexander V., et al.
Publicado: (2012)

A Practical Method for No-Reflow Treatment
por: Cetin, Mustafa, et al.
Publicado: (2016)

“No-Reflow” Phenomenon: A Contemporary Review
por: Annibali, Gianmarco, et al.
Publicado: (2022)

Coronary No-Reflow after Primary Percutaneous Coronary Intervention—Current Knowledge on Pathophysiology, Diagnosis, Clinical Impact and Therapy
por: Ndrepepa, Gjin, et al.
Publicado: (2023)

Using an Artificial Neural Network to Predict Coronary Microvascular Obstruction (No-Reflow Phenomenon) during Percutaneous Coronary Interventions in Patients with Myocardial Infarction
por: Frolov, A.A., et al.
Publicado: (2021)

No-Reflow Phenomenon During Treatment of Coronary In-Stent Restenosis With a Paclitaxel-Coated Balloon Catheter
por: Chung, Han-Hee, et al.
Publicado: (2012)

Evaluation of the Clinical and Procedural Predictive Factors of no-Reflow Phenomenon Following Primary Percutaneous Coronary Intervention
por: Abdi, Seifollah, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7or1viut15hbkedv3hlejhcfum